NEW YORK (GenomeWeb News) - Biolab will distribute GWC Technologies’ label-free array systems in Scandinavia, GWC said today.
 
Under the exclusive agreement, Biolab will offer the GWC detection systems to Scandinavian labs researching proteomics, cell biology, and food science, and to those developing novel array fabrication methods.
 
Over 50 percent of Madison, Wisc.-based GWC’s products are sold overseas, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.